Is cardiovascular magnetic resonance measurement of diffuse fibrosis ready for clinical use in the systemic RV?

Int J Cardiol. 2018 Nov 15:271:66-67. doi: 10.1016/j.ijcard.2018.06.095. Epub 2018 Jun 22.

Authors

Sarah Ghonim¹, Peter D Gatehouse¹, Michael A Gatzoulis¹, Sonya V Babu-Narayan²

Affiliations

¹ Royal Brompton and Harefield NHS Foundation Trust, National Heart and Lung Institute, Imperial College London, United Kingdom of Great Britain and Northern Ireland.
² Royal Brompton and Harefield NHS Foundation Trust, National Heart and Lung Institute, Imperial College London, United Kingdom of Great Britain and Northern Ireland. Electronic address: s.babu-narayan@rbht.nhs.uk.

PMID: 29970268
DOI: 10.1016/j.ijcard.2018.06.095

No abstract available

Publication types

Editorial
Comment

MeSH terms

Fibrosis*
Humans
Magnetic Resonance Imaging
Magnetic Resonance Imaging, Cine*
Magnetic Resonance Spectroscopy
Ventricular Function, Right

Grants and funding